Historical record - last NADAC effective date: 5/20/2020

Product Information

METOLAZONE 5 MG TABLET is a generic product labeled by Sandoz Inc., priced at $1.1811 per EA under NDC 00185005510. Its NADAC has been published 339 times since Nov 28, 2013.

FDA first approved this application on Dec 19, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Metolazone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

METOLAZONE 5 MG TABLET

Metolazone
$1.1811per EA
High Outlier

Strength

5 mg/1

Manufacturer

Sandoz Inc.

NDC

00185005510

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

5/20/2020

Active Ingredients

METOLAZONE

Approval Type

Generic (ANDA)

FDA Application

ANDA076466

FDA Approved

12/19/2003

TE Code

AB

On Market Since

12/19/2003

Pharmacological Classes

Increased Diuresis
Thiazide-like Diuretic

Price Statistics

The NADAC for METOLAZONE 5 MG TABLET has been published 339 times since Nov 28, 2013, and over the history we have for it it has risen 113.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1811 per EA
All-time high$1.5199 (May 11, 2016)
All-time low$0.5532 (Nov 28, 2013)
Median price$1.2877
Average price$1.2334
Largest weekly change+68.8% (Jun 25, 2014)
Weeks tracked339
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+113.5%

Last surveyed May 20, 2020 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 78% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METOLAZONE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METOLAZONE 5 MG TABLET, manufactured by Sandoz Inc., is $1.1811 per EA (NDC 00185005510), effective May 20, 2020.

How has the price of METOLAZONE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for METOLAZONE 5 MG TABLET has risen 113.5%. It has been tracked across 339 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METOLAZONE 5 MG TABLET?

Since Nov 28, 2013, the NADAC for METOLAZONE 5 MG TABLET has ranged from a low of $0.5532 (Nov 28, 2013) to a high of $1.5199 (May 11, 2016), with a median of $1.2877 per EA.

Are there cheaper alternatives to METOLAZONE 5 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METOLAZONE 5 MG TABLET, is $0.2643 per EA — about 78% below METOLAZONE 5 MG TABLET.

Who manufactures METOLAZONE 5 MG TABLET?

METOLAZONE 5 MG TABLET (NDC 00185005510) is labeled by Sandoz Inc., and CMS classifies it as a generic product.